Lynparza
Drug timelines are a Plus or Pro feature.
164 regulatory and trial events tracked for Lynparza, covering 2012-05-30 to 2026-08-12. Get the full timeline:
Most recent: EMA Authorised: Lynparza (olaparib) — AstraZeneca AB
164 regulatory and trial events tracked for Lynparza, covering 2012-05-30 to 2026-08-12. Get the full timeline:
Most recent: EMA Authorised: Lynparza (olaparib) — AstraZeneca AB